
Âé¶¹Ô´´ Analysis and Insights: Global Virology Specimen Collection Âé¶¹Ô´´
The global Virology Specimen Collection market is projected to grow from US$ 1962 million in 2024 to US$ 2425.8 million by 2030, at a Compound Annual Growth Rate (CAGR) of 3.6% during the forecast period.
The US & Canada market for Virology Specimen Collection is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Virology Specimen Collection is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Virology Specimen Collection is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key companies of Virology Specimen Collection include Becton,Dickinson and Company, Quidel Corporation, Trinity Biotech, Titan Biotech, Diasorin SA, Vircell S.L., Copan Italia S.P.A, Puritan Medical Products Co. and Hardy Diagnostics, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Virology Specimen Collection is widely used in various fields, such as Biopharmaceutical Companies and Academic and Research Institutes, etc. Biopharmaceutical Companies provides greatest supports to the Virology Specimen Collection industry development. In 2023, global % revenue of Virology Specimen Collection went into Biopharmaceutical Companies filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for Virology Specimen Collection market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Virology Specimen Collection, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Virology Specimen Collection, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Virology Specimen Collection revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Virology Specimen Collection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Virology Specimen Collection revenue, projected growth trends, production technology, application and end-user industry.
Âé¶¹Ô´´ Segmentation
By Company
Becton,Dickinson and Company
Quidel Corporation
Trinity Biotech
Titan Biotech
Diasorin SA
Vircell S.L.
Copan Italia S.P.A
Puritan Medical Products Co.
Hardy Diagnostics
Cardinal Health
Sarstedt
FL Medical
Improve Medical
Segment by Type
Blood Collection Kits
Specimen Collection Tubes
Viral Transport Media
Swabs
Segment by Application
Biopharmaceutical Companies
Academic and Research Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Virology Specimen Collection in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Virology Specimen Collection companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Virology Specimen Collection revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Âé¶¹Ô´´ Analysis by Type
1.2.1 Global Virology Specimen Collection Âé¶¹Ô´´ Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Blood Collection Kits
1.2.3 Specimen Collection Tubes
1.2.4 Viral Transport Media
1.2.5 Swabs
1.3 Âé¶¹Ô´´ by Application
1.3.1 Global Virology Specimen Collection Âé¶¹Ô´´ Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Biopharmaceutical Companies
1.3.3 Academic and Research Institutes
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Virology Specimen Collection Âé¶¹Ô´´ Perspective (2019-2030)
2.2 Global Virology Specimen Collection Growth Trends by Region
2.2.1 Virology Specimen Collection Âé¶¹Ô´´ Size by Region: 2019 VS 2023 VS 2030
2.2.2 Virology Specimen Collection Historic Âé¶¹Ô´´ Size by Region (2019-2024)
2.2.3 Virology Specimen Collection Forecasted Âé¶¹Ô´´ Size by Region (2025-2030)
2.3 Virology Specimen Collection Âé¶¹Ô´´ Dynamics
2.3.1 Virology Specimen Collection Industry Trends
2.3.2 Virology Specimen Collection Âé¶¹Ô´´ Drivers
2.3.3 Virology Specimen Collection Âé¶¹Ô´´ Challenges
2.3.4 Virology Specimen Collection Âé¶¹Ô´´ Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Virology Specimen Collection by Players
3.1.1 Global Virology Specimen Collection Revenue by Players (2019-2024)
3.1.2 Global Virology Specimen Collection Revenue Âé¶¹Ô´´ Share by Players (2019-2024)
3.2 Global Virology Specimen Collection Âé¶¹Ô´´ Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Virology Specimen Collection, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Virology Specimen Collection Âé¶¹Ô´´ Concentration Ratio
3.4.1 Global Virology Specimen Collection Âé¶¹Ô´´ Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Virology Specimen Collection Revenue in 2023
3.5 Global Key Players of Virology Specimen Collection Head office and Area Served
3.6 Global Key Players of Virology Specimen Collection, Product and Application
3.7 Global Key Players of Virology Specimen Collection, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Virology Specimen Collection Breakdown Data by Type
4.1 Global Virology Specimen Collection Historic Âé¶¹Ô´´ Size by Type (2019-2024)
4.2 Global Virology Specimen Collection Forecasted Âé¶¹Ô´´ Size by Type (2025-2030)
5 Virology Specimen Collection Breakdown Data by Application
5.1 Global Virology Specimen Collection Historic Âé¶¹Ô´´ Size by Application (2019-2024)
5.2 Global Virology Specimen Collection Forecasted Âé¶¹Ô´´ Size by Application (2025-2030)
6 North America
6.1 North America Virology Specimen Collection Âé¶¹Ô´´ Size (2019-2030)
6.2 North America Virology Specimen Collection Âé¶¹Ô´´ Size by Type
6.2.1 North America Virology Specimen Collection Âé¶¹Ô´´ Size by Type (2019-2024)
6.2.2 North America Virology Specimen Collection Âé¶¹Ô´´ Size by Type (2025-2030)
6.2.3 North America Virology Specimen Collection Âé¶¹Ô´´ Share by Type (2019-2030)
6.3 North America Virology Specimen Collection Âé¶¹Ô´´ Size by Application
6.3.1 North America Virology Specimen Collection Âé¶¹Ô´´ Size by Application (2019-2024)
6.3.2 North America Virology Specimen Collection Âé¶¹Ô´´ Size by Application (2025-2030)
6.3.3 North America Virology Specimen Collection Âé¶¹Ô´´ Share by Application (2019-2030)
6.4 North America Virology Specimen Collection Âé¶¹Ô´´ Size by Country
6.4.1 North America Virology Specimen Collection Âé¶¹Ô´´ Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Virology Specimen Collection Âé¶¹Ô´´ Size by Country (2019-2024)
6.4.3 North America Virology Specimen Collection Âé¶¹Ô´´ Size by Country (2025-2030)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Virology Specimen Collection Âé¶¹Ô´´ Size (2019-2030)
7.2 Europe Virology Specimen Collection Âé¶¹Ô´´ Size by Type
7.2.1 Europe Virology Specimen Collection Âé¶¹Ô´´ Size by Type (2019-2024)
7.2.2 Europe Virology Specimen Collection Âé¶¹Ô´´ Size by Type (2025-2030)
7.2.3 Europe Virology Specimen Collection Âé¶¹Ô´´ Share by Type (2019-2030)
7.3 Europe Virology Specimen Collection Âé¶¹Ô´´ Size by Application
7.3.1 Europe Virology Specimen Collection Âé¶¹Ô´´ Size by Application (2019-2024)
7.3.2 Europe Virology Specimen Collection Âé¶¹Ô´´ Size by Application (2025-2030)
7.3.3 Europe Virology Specimen Collection Âé¶¹Ô´´ Share by Application (2019-2030)
7.4 Europe Virology Specimen Collection Âé¶¹Ô´´ Size by Country
7.4.1 Europe Virology Specimen Collection Âé¶¹Ô´´ Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Virology Specimen Collection Âé¶¹Ô´´ Size by Country (2019-2024)
7.4.3 Europe Virology Specimen Collection Âé¶¹Ô´´ Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Virology Specimen Collection Âé¶¹Ô´´ Size (2019-2030)
8.2 China Virology Specimen Collection Âé¶¹Ô´´ Size by Type
8.2.1 China Virology Specimen Collection Âé¶¹Ô´´ Size by Type (2019-2024)
8.2.2 China Virology Specimen Collection Âé¶¹Ô´´ Size by Type (2025-2030)
8.2.3 China Virology Specimen Collection Âé¶¹Ô´´ Share by Type (2019-2030)
8.3 China Virology Specimen Collection Âé¶¹Ô´´ Size by Application
8.3.1 China Virology Specimen Collection Âé¶¹Ô´´ Size by Application (2019-2024)
8.3.2 China Virology Specimen Collection Âé¶¹Ô´´ Size by Application (2025-2030)
8.3.3 China Virology Specimen Collection Âé¶¹Ô´´ Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Virology Specimen Collection Âé¶¹Ô´´ Size (2019-2030)
9.2 Asia Virology Specimen Collection Âé¶¹Ô´´ Size by Type
9.2.1 Asia Virology Specimen Collection Âé¶¹Ô´´ Size by Type (2019-2024)
9.2.2 Asia Virology Specimen Collection Âé¶¹Ô´´ Size by Type (2025-2030)
9.2.3 Asia Virology Specimen Collection Âé¶¹Ô´´ Share by Type (2019-2030)
9.3 Asia Virology Specimen Collection Âé¶¹Ô´´ Size by Application
9.3.1 Asia Virology Specimen Collection Âé¶¹Ô´´ Size by Application (2019-2024)
9.3.2 Asia Virology Specimen Collection Âé¶¹Ô´´ Size by Application (2025-2030)
9.3.3 Asia Virology Specimen Collection Âé¶¹Ô´´ Share by Application (2019-2030)
9.4 Asia Virology Specimen Collection Âé¶¹Ô´´ Size by Region
9.4.1 Asia Virology Specimen Collection Âé¶¹Ô´´ Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Virology Specimen Collection Âé¶¹Ô´´ Size by Region (2019-2024)
9.4.3 Asia Virology Specimen Collection Âé¶¹Ô´´ Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Virology Specimen Collection Âé¶¹Ô´´ Size (2019-2030)
10.2 Middle East, Africa, and Latin America Virology Specimen Collection Âé¶¹Ô´´ Size by Type
10.2.1 Middle East, Africa, and Latin America Virology Specimen Collection Âé¶¹Ô´´ Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Virology Specimen Collection Âé¶¹Ô´´ Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Virology Specimen Collection Âé¶¹Ô´´ Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Virology Specimen Collection Âé¶¹Ô´´ Size by Application
10.3.1 Middle East, Africa, and Latin America Virology Specimen Collection Âé¶¹Ô´´ Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Virology Specimen Collection Âé¶¹Ô´´ Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Virology Specimen Collection Âé¶¹Ô´´ Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Virology Specimen Collection Âé¶¹Ô´´ Size by Country
10.4.1 Middle East, Africa, and Latin America Virology Specimen Collection Âé¶¹Ô´´ Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Virology Specimen Collection Âé¶¹Ô´´ Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Virology Specimen Collection Âé¶¹Ô´´ Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Becton,Dickinson and Company
11.1.1 Becton,Dickinson and Company Company Details
11.1.2 Becton,Dickinson and Company Business Overview
11.1.3 Becton,Dickinson and Company Virology Specimen Collection Introduction
11.1.4 Becton,Dickinson and Company Revenue in Virology Specimen Collection Business (2019-2024)
11.1.5 Becton,Dickinson and Company Recent Developments
11.2 Quidel Corporation
11.2.1 Quidel Corporation Company Details
11.2.2 Quidel Corporation Business Overview
11.2.3 Quidel Corporation Virology Specimen Collection Introduction
11.2.4 Quidel Corporation Revenue in Virology Specimen Collection Business (2019-2024)
11.2.5 Quidel Corporation Recent Developments
11.3 Trinity Biotech
11.3.1 Trinity Biotech Company Details
11.3.2 Trinity Biotech Business Overview
11.3.3 Trinity Biotech Virology Specimen Collection Introduction
11.3.4 Trinity Biotech Revenue in Virology Specimen Collection Business (2019-2024)
11.3.5 Trinity Biotech Recent Developments
11.4 Titan Biotech
11.4.1 Titan Biotech Company Details
11.4.2 Titan Biotech Business Overview
11.4.3 Titan Biotech Virology Specimen Collection Introduction
11.4.4 Titan Biotech Revenue in Virology Specimen Collection Business (2019-2024)
11.4.5 Titan Biotech Recent Developments
11.5 Diasorin SA
11.5.1 Diasorin SA Company Details
11.5.2 Diasorin SA Business Overview
11.5.3 Diasorin SA Virology Specimen Collection Introduction
11.5.4 Diasorin SA Revenue in Virology Specimen Collection Business (2019-2024)
11.5.5 Diasorin SA Recent Developments
11.6 Vircell S.L.
11.6.1 Vircell S.L. Company Details
11.6.2 Vircell S.L. Business Overview
11.6.3 Vircell S.L. Virology Specimen Collection Introduction
11.6.4 Vircell S.L. Revenue in Virology Specimen Collection Business (2019-2024)
11.6.5 Vircell S.L. Recent Developments
11.7 Copan Italia S.P.A
11.7.1 Copan Italia S.P.A Company Details
11.7.2 Copan Italia S.P.A Business Overview
11.7.3 Copan Italia S.P.A Virology Specimen Collection Introduction
11.7.4 Copan Italia S.P.A Revenue in Virology Specimen Collection Business (2019-2024)
11.7.5 Copan Italia S.P.A Recent Developments
11.8 Puritan Medical Products Co.
11.8.1 Puritan Medical Products Co. Company Details
11.8.2 Puritan Medical Products Co. Business Overview
11.8.3 Puritan Medical Products Co. Virology Specimen Collection Introduction
11.8.4 Puritan Medical Products Co. Revenue in Virology Specimen Collection Business (2019-2024)
11.8.5 Puritan Medical Products Co. Recent Developments
11.9 Hardy Diagnostics
11.9.1 Hardy Diagnostics Company Details
11.9.2 Hardy Diagnostics Business Overview
11.9.3 Hardy Diagnostics Virology Specimen Collection Introduction
11.9.4 Hardy Diagnostics Revenue in Virology Specimen Collection Business (2019-2024)
11.9.5 Hardy Diagnostics Recent Developments
11.10 Cardinal Health
11.10.1 Cardinal Health Company Details
11.10.2 Cardinal Health Business Overview
11.10.3 Cardinal Health Virology Specimen Collection Introduction
11.10.4 Cardinal Health Revenue in Virology Specimen Collection Business (2019-2024)
11.10.5 Cardinal Health Recent Developments
11.11 Sarstedt
11.11.1 Sarstedt Company Details
11.11.2 Sarstedt Business Overview
11.11.3 Sarstedt Virology Specimen Collection Introduction
11.11.4 Sarstedt Revenue in Virology Specimen Collection Business (2019-2024)
11.11.5 Sarstedt Recent Developments
11.12 FL Medical
11.12.1 FL Medical Company Details
11.12.2 FL Medical Business Overview
11.12.3 FL Medical Virology Specimen Collection Introduction
11.12.4 FL Medical Revenue in Virology Specimen Collection Business (2019-2024)
11.12.5 FL Medical Recent Developments
11.13 Improve Medical
11.13.1 Improve Medical Company Details
11.13.2 Improve Medical Business Overview
11.13.3 Improve Medical Virology Specimen Collection Introduction
11.13.4 Improve Medical Revenue in Virology Specimen Collection Business (2019-2024)
11.13.5 Improve Medical Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Becton,Dickinson and Company
Quidel Corporation
Trinity Biotech
Titan Biotech
Diasorin SA
Vircell S.L.
Copan Italia S.P.A
Puritan Medical Products Co.
Hardy Diagnostics
Cardinal Health
Sarstedt
FL Medical
Improve Medical
Ìý
Ìý
*If Applicable.
